Eltrog 25mg Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Eltrombopag (25mg)
Overview Eltrog 25mg Tablet
Eltromab 25mg tablets are indicated for managing low platelet levels stemming from chronic immune thrombocytopenic purpura (ITP) or persistent hepatitis C virus (HCV) infection. This medication also addresses severe aplastic anemia. Eltromab 25mg is a thrombopoietin receptor agonist, prompting increased platelet production. Platelets are crucial for hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. It can be taken on an empty stomach and should be swallowed whole; do not crush, chew, or break the tablet. Report any known drug allergies to your doctor. Common adverse reactions include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Report any bothersome side effects to your doctor for potential symptom management strategies. Before commencing treatment, disclose any pre-existing health issues and all other medications you're using. Liver impairment may necessitate dose modification; consult your physician.
Uses of Eltrog 25mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; management of critically low bone marrow function.
Major Benefits of Eltrog 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 25mg Eltrog tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Eltrog 25mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Eltrog 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 25mg Eltrog tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Eltrog 25mg Tablet works:
Promacta 25mg tablets stimulate platelet production. This medication, a thrombopoietin receptor agonist, increases the number of platelets in the bloodstream, thus lessening the risk of hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Eltrog 25mg Tablet with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Eltrog 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Eltrog 25mg tablets are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Eltrog 25mg Tablet, which can induce dizziness and reduced alertness, thus impacting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Eltrog 25mg Tablets without a recommended dosage change. Nevertheless, disclose any kidney conditions to your physician. Routine monitoring of kidney function is suggested during treatment.
LiverCAUTION
Patients with liver impairment should use Eltrog 25mg tablets cautiously; dosage modification may be necessary. A physician's consultation is advised.
What if you forget to take Eltrog 25mg Tablet :
Omit any missed Eltrog 25mg Tablet dose; resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Eltrog 25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Thrombopoietin receptor activator |
3,018 People bought this recently